Study identifies apolipoprotein as target for diabetes drug

normal

New research from the University of Cincinnati (UC) points to the naturally produced protein apolipoprotein A-IV (apoA-IV) as a potential target for a new diabetes therapeutic.

Read more

Posted in Drugs Medical Research